Crossref
Cluster of differentiation 40 agonism as a priming strategy in pancreatic ductal adenocarcinoma: biomarker insights from OPTIMIZE-1
Annals of Pancreatic Cancer · 2026-05 · 9 · 12-12
DOI: 10.21037/apc-26-0010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-05. Verfasst von Kai-Li Liang und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liang, K., & Christenson, E. S. (2026). Cluster of differentiation 40 agonism as a priming strategy in pancreatic ductal adenocarcinoma: biomarker insights from OPTIMIZE-1. Annals of Pancreatic Cancer, 9, 12-12. https://doi.org/10.21037/apc-26-0010
Vancouver
Liang K, Christenson ES. Cluster of differentiation 40 agonism as a priming strategy in pancreatic ductal adenocarcinoma: biomarker insights from OPTIMIZE-1. Annals of Pancreatic Cancer. 2026;9:12-12. doi:10.21037/apc-26-0010
BibTeX
@article{Liang2026,
author = {Liang, Kai-Li and Christenson, Eric S.},
title = {Cluster of differentiation 40 agonism as a priming strategy in pancreatic ductal adenocarcinoma: biomarker insights from OPTIMIZE-1},
journal = {Annals of Pancreatic Cancer},
year = {2026},
volume = {9},
pages = {12--12},
doi = {10.21037/apc-26-0010}
}
EUVIMED